Clinical Effectiveness and Feasibility Study on Quality-of-life Measure for Chronic Myeloid Leukemia Treated with Imatinib at a Medical Center in Southern Taiwan
碩士 === 高雄醫學大學 === 臨床藥學研究所 === 100 === Background: Since the launch of Imatinib, the survival and disease progression of chronic myeloid leukemia (CML) has significantly improved, but also resulted in enormous increase in long-term costs. However, neither clinical outcomes nor health-related utility...
Main Authors: | Teng-Chou Chen, 陳謄州 |
---|---|
Other Authors: | Yaw-Bin Huang |
Format: | Others |
Language: | zh-TW |
Published: |
2012
|
Online Access: | http://ndltd.ncl.edu.tw/handle/52253885384713828095 |
Similar Items
-
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
by: Tomasz Sacha
Published: (2013-12-01) -
Imatinib en leucemia mieloide crónica Imatinib in chronic myeloid leukemia
by: Valia Pavón Morán, et al.
Published: (2005-12-01) -
A Case with Neurofibromatosis and Chronic Myeloid Leukemia in Blastic Crisis Treated with Imatinib
by: Gamal Abdul Hamid, et al.
Published: (2014-03-01) -
Comparative study for the efficacy, safety and quality of life in patients of chronic myeloid leukemia treated with Imatinib or Hydroxyurea
by: Parveen Jain, et al.
Published: (2013-01-01) -
Monitoring imatinib plasma concentrations in chronic myeloid leukemia
by: Darlize Hübner Martins, et al.
Published: (2011-01-01)